Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Czech Myeloma Group"'
Autor:
Jiri Minarik, Petr Pavlicek, Ludek Pour, Tomas Pika, Vladimir Maisnar, Ivan Spicka, Jiri Jarkovsky, Marta Krejci, Jaroslav Bacovsky, Jakub Radocha, Jan Straub, Petr Kessler, Marek Wrobel, Lenka Walterova, Michal Sykora, Jarmila Obernauerova, Lucie Brozova, Evzen Gregora, Dagmar Adamova, Jaromir Gumulec, Zdenek Adam, Vlastimil Scudla, Roman Hajek, Czech Myeloma Group
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123866 (2015)
OBJECTIVE:Subcutaneous (SC) application of bortezomib has been recently introduced as a new application route in multiple myeloma (MM) patients. We performed an analysis to compare the outcomes of bortezomib-based therapy in multiple myeloma (MM) pat
Externí odkaz:
https://doaj.org/article/781e01a2fb62439984783e51c9bbd51c
Autor:
Jiri Minarik, Petr Pavlicek, Ludek Pour, Tomas Pika, Vladimir Maisnar, Ivan Spicka, Jiri Jarkovsky, Marta Krejci, Jaroslav Bacovsky, Jakub Radocha, Jan Straub, Petr Kessler, Marek Wrobel, Lenka Walterova, Michal Sykora, Jarmila Obernauerova, Lucie Brozova, Evzen Gregora, Dagmar Adamova, Jaromir Gumulec, Zdenek Adam, Vlastimil Scudla, Roman Hajek, Czech Myeloma Group
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 4, p e0123866 (2015)
PLoS ONE, Vol 10, Iss 4, p e0123866 (2015)
OBJECTIVE:Subcutaneous (SC) application of bortezomib has been recently introduced as a new application route in multiple myeloma (MM) patients. We performed an analysis to compare the outcomes of bortezomib-based therapy in multiple myeloma (MM) pat
Publikováno v:
Colloids and Surfaces A: Physicochemical and Engineering Aspects
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2016, 496, pp.114-124. ⟨10.1016/j.colsurfa.2015.10.048⟩
Colloids and Surfaces A: Physicochemical and Engineering Aspects, Elsevier, 2016, 496, pp.114-124. ⟨10.1016/j.colsurfa.2015.10.048⟩
ResearcherID
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2016, 496, pp.114-124. ⟨10.1016/j.colsurfa.2015.10.048⟩
Colloids and Surfaces A: Physicochemical and Engineering Aspects, Elsevier, 2016, 496, pp.114-124. ⟨10.1016/j.colsurfa.2015.10.048⟩
ResearcherID
Two novel three-dimensional microporous coordination polymers with composition {[Ln(μ6-BTC)(H2O)]·DMF}n (Ln = Ho(III) (1) and Tm(III) (2); BTC-benzene-1,3,5-tricarboxylate) have been solvothermally synthesized and their preparation conditions were
Autor:
Hana Šváchová, Pavel Nemec, L. Kovarova, Zdenek Adam, Miroslav Penka, Ludek Pour, Lucie Burešová, Martina Almáši, Roman Hájek, Tomas Buchler, Jiri Vorlicek
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2009, 89 (4), pp.385-389. ⟨10.1007/s00277-009-0834-3⟩
Annals of Hematology, Springer Verlag, 2009, 89 (4), pp.385-389. ⟨10.1007/s00277-009-0834-3⟩
International audience; Angiogenesis plays a significant role in the pathogenesis of multiple myeloma (MM). We have measured concentrations of angiogenesis activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth facto
Autor:
Radocha J; Faculty of Medicine in Hradec Králové, 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.; Czech Myeloma Group, Brno, Czech Republic., Jelinek T; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Pour L; Czech Myeloma Group, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Usti nad Labem, Czech Republic., Spicka I; Czech Myeloma Group, Brno, Czech Republic.; 1st Medical Department - Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Minarik J; Czech Myeloma Group, Brno, Czech Republic.; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic., Popkova T; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Jungova A; Czech Myeloma Group, Brno, Czech Republic.; Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic., Pavlicek P; Czech Myeloma Group, Brno, Czech Republic.; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic., Brozova L; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic., Stork M; Czech Myeloma Group, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Usti nad Labem, Czech Republic., Sedlak F; Czech Myeloma Group, Brno, Czech Republic.; 1st Medical Department - Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Krhovska P; Czech Myeloma Group, Brno, Czech Republic.; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic., Maisnar V; Faculty of Medicine in Hradec Králové, 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.; Czech Myeloma Group, Brno, Czech Republic., Heindorfer A; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematology, Hospital Liberec, Liberec, Czech Republic., Sykora M; Czech Myeloma Group, Brno, Czech Republic.; Department of Clinical Hematology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic., Wrobel M; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematology, Hospital Novy Jicin, Novy Jicin, Czech Republic., Mikula P; Czech Myeloma Group, Brno, Czech Republic.; Department of Clinical Haematology, Hospital in Havirov, Havirov, Czech Republic., Kessler P; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematology and Transfusion Medicine, Hospital Pelhrimov, Pelhrimov, Czech Republic., Ullrychova J; Czech Myeloma Group, Brno, Czech Republic.; Department of Clinical Hematology, Regional Health Corporation, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic., Hajek R; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Publikováno v:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Oct; Vol. 43 (5), pp. e244-e247. Date of Electronic Publication: 2021 Jan 16.
Autor:
Radocha J; 4th Department of Internal Medicine - Hematology, Faculty Hospital, Charles University, Hradec Králové, Czech Republic. jakub.radocha@centrum.cz.; Czech Myeloma Group, Brno, Czech Republic. jakub.radocha@centrum.cz., Hájek R; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic., Brožová L; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Pour L; Czech Myeloma Group, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine Masaryk Universtiy, University Hospital Brno, Brno, Czech Republic., Špička I; Czech Myeloma Group, Brno, Czech Republic.; 1st Medical Department - Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital, Charles University, Prague, Czech Republic., Minařík J; Czech Myeloma Group, Brno, Czech Republic.; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University, University Hospital Olomouc, Olomouc, Czech Republic., Gregora E; Czech Myeloma Group, Brno, Czech Republic.; Department of Internal Medicine and Hematology, 3rd Faculty of Medicine, Charles University, Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic., Jungová A; Czech Myeloma Group, Brno, Czech Republic.; Hematology and Oncology Department, Charles University Hospital Pilsen, Prague, Czech Republic., Jelínek T; Czech Myeloma Group, Brno, Czech Republic.; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic., Heindorfer A; Czech Myeloma Group, Brno, Czech Republic.; Department of Clinical Hematology, Hospital Liberec, Liberec, Czech Republic., Sýkora M; Czech Myeloma Group, Brno, Czech Republic.; Department of Clinical Hematology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic., Maisnar V; 4th Department of Internal Medicine - Hematology, Faculty Hospital, Charles University, Hradec Králové, Czech Republic.; Czech Myeloma Group, Brno, Czech Republic.
Publikováno v:
Annals of hematology [Ann Hematol] 2019 Apr; Vol. 98 (4), pp. 951-962. Date of Electronic Publication: 2018 Dec 11.
Autor:
Cumova J; University Research Centre - The Czech Myeloma Group (URC-CMG), Babak Research Institute, Faculty of Medicine, Masaryk University, Kamenice 5/A3, 625 00, Brno, Czech Republic. jazze@centrum.cz, Potacova A, Zdrahal Z, Hajek R
Publikováno v:
Molecular biotechnology [Mol Biotechnol] 2011 Jan; Vol. 47 (1), pp. 83-93.
Autor:
Dementyeva E; University Research Centre, Czech Myeloma Group, Babak Research Institute, Masaryk University, Brno, Czech Republic., Nemec P, Kryukov F, Muthu Raja KR, Smetana J, Zaoralova R, Greslikova H, Kupska R, Kuglik P, Hajek R
Publikováno v:
Leukemia research [Leuk Res] 2010 Aug; Vol. 34 (8), pp. 1007-11. Date of Electronic Publication: 2010 Jan 21.
Autor:
Raja KR; University Research Centre-Czech Myeloma Group, Kamenice 5, Bohunice, Brno 62500, Czech Republic. rajakarthick594@gmail.com, Kovarova L, Hajek R
Publikováno v:
British journal of haematology [Br J Haematol] 2010 May; Vol. 149 (3), pp. 334-51. Date of Electronic Publication: 2010 Mar 01.
Autor:
Nemec P; University Research Centre, Czech Myeloma Group, Masaryk University, Kamenice 5,Brno, Czech Republic. handcock@mail.muni.cz, Zemanova Z, Greslikova H, Michalova K, Filkova H, Tajtlova J, Kralova D, Kupska R, Smetana J, Krejci M, Pour L, Zahradova L, Sandecka V, Adam Z, Buchler T, Spicka I, Gregora E, Kuglik P, Hajek R
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2010 Apr; Vol. 16 (4), pp. 548-54. Date of Electronic Publication: 2010 Jan 18.